01082nas a2200445   4500000000100000008004100001260001300042653001500055653001000070653002400080653001600104653002300120653001000143653002100153653001100174653001100185653001800196653001100214653001200225653000900237653001600246653002500262653001500287653001700302653001600319653001400335100001300349700001500362700001300377700001300390700001600403700001800419700001500437245005200452856006400504300001000568490001200578050003200590022001400622       1983                            d  c1983 Jun10aAdolescent10aAdult10aAntigens, Bacterial10aBCG Vaccine10aBacterial Vaccines10aChild10aChild, Preschool10aFemale10aHumans10aImmunotherapy10aInfant10aleprosy10aMale10aMiddle Aged10aMycobacterium leprae10aSkin Tests10aTime Factors10aVaccination10aVenezuela1 aConvit J1 aAranzazu N1 aZuniga M1 aUlrich M1 aPinardi M E1 aCastellazzi Z1 aAlvarado J00aImmunotherapy and immunoprophylaxis of leprosy.  uhttp://leprev.ilsl.br/pdfs/1983/v54nesp1/pdf/v54nespa07.pdf  a47-600 vSpec No  aInfolep Library - available  a0305-7518